Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rigel Pharmaceutical Inc. buy Citigroup Inc.

Start price
€0.74
12.11.24 / 50%
Target price
€46.15
12.11.25
Performance (%)
-
End price
-
13.11.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Rigel Pharmaceutical Inc. - - -
iShares Core DAX® 0.060% 1.215% 18.128%
iShares Nasdaq 100 -3.065% -0.519% 2.080%
iShares Nikkei 225® -2.094% -3.066% 11.655%
iShares S&P 500 -1.657% -0.069% 1.103%

Comments by Citigroup_Inc_ for this prediction

In the thread Rigel Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 46.153
Change
Ends at 12.11.25

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $40.00 to $49.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat

In the thread Trading Rigel Pharmaceutical Inc.
Prediction Buy
Perf. (%) -
Target price 46.153
Change
Ends at 12.11.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Current prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€0.74
06.03.25
€50.83
06.03.26
-
26.06.24

Stopped prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.40
07.03.24
€3.67
07.03.25
-47.24%
08.03.25